<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>The selected-candidate compounds with CC
   <sub>50</sub> and EC
   <sub>50</sub> values from the cell-based assays.
  </p>
 </caption>
 <alt-text id="alttext0055">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="3">no.</th>
    <th rowspan="3">Compound ID</th>
    <th colspan="7">Cell-based assay
     <xref rid="tbl1fnb" ref-type="table-fn">b</xref>
     <hr/>
    </th>
   </tr>
   <tr>
    <th rowspan="2">Cytotoxicity CC
     <sub>50</sub> (μM)
     <xref rid="tbl1fna" ref-type="table-fn">a</xref>
    </th>
    <th colspan="2">Pre-viral entry (EC
     <sub>50</sub>; μM)
     <xref rid="tbl1fnc" ref-type="table-fn">c</xref>
     <hr/>
    </th>
    <th colspan="2">Post-viral entry (EC
     <sub>50</sub>; μM)
     <xref rid="tbl1fnd" ref-type="table-fn">d</xref>
     <hr/>
    </th>
    <th colspan="2">Prophylactic antiviral activity (EC
     <sub>50</sub>; μM)
     <xref rid="tbl1fne" ref-type="table-fn">e</xref>
     <hr/>
    </th>
   </tr>
   <tr>
    <th>IPMA</th>
    <th>SI</th>
    <th>IPMA</th>
    <th>SI</th>
    <th>IPMA</th>
    <th>SI</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">1</td>
    <td align="left">NSC345647</td>
    <td align="left">10.53 ± 0.13</td>
    <td align="left">1.19 ± 0.95</td>
    <td align="left">8.88</td>
    <td align="left">4.867 ± 0.12</td>
    <td align="left">2.20</td>
    <td align="left">2.851 ± 0.520</td>
    <td align="left">3.69</td>
   </tr>
   <tr>
    <td align="left">2</td>
    <td align="left">NSC87511</td>
    <td align="left">371.90 ± 0.26</td>
    <td align="left">16.24 ± 1.33</td>
    <td align="left">22.90</td>
    <td align="left">21.83 ± 1.64</td>
    <td align="left">17.04</td>
    <td align="left">26.94 ± 1.25</td>
    <td align="left">13.80</td>
   </tr>
   <tr>
    <td align="left">3</td>
    <td align="left">NSC343256</td>
    <td align="left">56.87 ± 0.73</td>
    <td align="left">3.83 ± 0.44</td>
    <td align="left">2.89</td>
    <td align="left">4.00 ± 0.37</td>
    <td align="left">2.77</td>
    <td align="left">16.22 ± 1.23</td>
    <td align="left">0.68</td>
   </tr>
   <tr>
    <td align="left">4</td>
    <td align="left">CID5318214</td>
    <td align="left">339.30 ± 0.03</td>
    <td align="left">&gt;100</td>
    <td align="left">N/A</td>
    <td align="left">&gt;100</td>
    <td align="left">N/A</td>
    <td align="left">&gt;200</td>
    <td align="left">N/A</td>
   </tr>
   <tr>
    <td align="left">5</td>
    <td align="left">CID3821945</td>
    <td align="left">306.8 ± 0.175</td>
    <td align="left">&gt;100</td>
    <td align="left">N/A</td>
    <td align="left">&gt;100</td>
    <td align="left">N/A</td>
    <td align="left">&gt;200</td>
    <td align="left">N/A</td>
   </tr>
   <tr>
    <td align="left">6</td>
    <td align="left">CID 5748601</td>
    <td align="left">425.30 ± 0.13</td>
    <td align="left">&gt;100</td>
    <td align="left">N/A</td>
    <td align="left">&gt;100</td>
    <td align="left">N/A</td>
    <td align="left">&gt;200</td>
    <td align="left">N/A</td>
   </tr>
   <tr>
    <td align="left">7</td>
    <td align="left">CID5372747</td>
    <td align="left">336.20 ± 0.13</td>
    <td align="left">&gt;100</td>
    <td align="left">N/A</td>
    <td align="left">&gt;200</td>
    <td align="left">N/A</td>
    <td align="left">&gt;200</td>
    <td align="left">N/A</td>
   </tr>
   <tr>
    <td align="left">Ribavirin</td>
    <td align="left">CID37542</td>
    <td align="left">&gt;500</td>
    <td align="left">48.87 ± 1.77</td>
    <td align="left">25.68</td>
    <td align="left">73.98 ± 0.18</td>
    <td align="left">16.96</td>
    <td align="left">&gt;200</td>
    <td align="left">N/A</td>
   </tr>
   <tr>
    <td align="left">Lopinavir</td>
    <td align="left">CID92727</td>
    <td align="left">&gt;500</td>
    <td align="left">8.56 ± 0.47</td>
    <td align="left">61.52</td>
    <td align="left">5.38 ± 2.32</td>
    <td align="left">97.83</td>
    <td align="left">31.70 ± 1.37</td>
    <td align="left">16.61</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>ND not determined.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl1fna">
   <label>a</label>
   <p id="ntpara0010">Fifty percent of cytotoxic concentration (CC
    <sub>50</sub>) by MTS assay.
   </p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl1fnb">
   <label>b</label>
   <p id="ntpara0015">The results show three independent cell-based assays to determine the effective concentration (EC
    <sub>50</sub>) using MTS and IPMA assays; Selectivity index (SI) = CC
    <sub>50</sub>/EC
    <sub>50</sub>.
   </p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl1fnc">
   <label>c</label>
   <p id="ntpara0020">100 TCID
    <sub>50</sub> FIPV incubation with compounds.
   </p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl1fnd">
   <label>d</label>
   <p id="ntpara0025">100 TCID
    <sub>50</sub> FIPV adsorption at 37 °C for 2 h before adding the tested compounds.
   </p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl1fne">
   <label>e</label>
   <p id="ntpara0030">Compound incubation at 37 °C for 2 h, before inoculation with FIPV at 100 TCID
    <sub>50</sub>/well.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
